Theriva Biologics Inc Sustainability Reports

Theriva Biologics Inc. is a publicly traded biotechnology company that develops and commercializes innovative therapeutics for the treatment of serious diseases.

Sector: Health Care

Country: United States

Exchange: NYSE American

ISIN: US87164U5083

3 reports from 2022 to 2024

Company Profile

Theriva Biologics Inc

Theriva Biologics Inc. is a publicly traded biotechnology company that develops and commercializes innovative therapeutics for the treatment of serious diseases.

MIC

 

Ticker

 

ISIN

 

Website

therivabio.com

Country

United States

Exchange

NYSE American

Sector

Health Care

Industry

Pharmaceuticals, Biotechnology & Life Sciences

Reports

Available reports